STOCK TITAN

BCYC insider sales include 2,937 restricted shares (NASDAQ: BCYC)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BCYC insider reported planned and recent share sales. The filing lists 2,937 restricted shares to be sold on 04/02/2026 as equity compensation. It also reports prior sales by Alethia Young of 3,289 shares on 04/02/2026 for $22,358.62 and 4,334 shares on 01/05/2026 for $28,113.16.

Positive

  • None.

Negative

  • None.

Insights

Routine Form 144 disclosure of insider sales and a planned restricted-share sale.

The filing lists a proposed sale of 2,937 restricted shares dated 04/02/2026 and records two recent dispositions by Alethia Young: 3,289 shares ($22,358.62) and 4,334 shares ($28,113.16).

These entries appear administrative and consistent with insider reporting requirements; the excerpt does not state proceeds recipient, trading method, or any conditioning language.

Planned restricted shares to be sold 2,937 shares to be sold on 04/02/2026 (Equity Compensation)
Recent sale by Alethia Young 3,289 shares sold on 04/02/2026 for $22,358.62
Recent sale by Alethia Young 4,334 shares sold on 01/05/2026 for $28,113.16
Filer address / broker Stifel Nicolaus & Company Inc 501 N Broadway, St. Louis; Nasdaq noted in header
Restricted Stock financial
"Common Stock | 04/02/2026 | Restricted Stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.
Equity Compensation financial
"2937 | 04/02/2026 | Equity Compensation"
Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.
Form 144 regulatory
"form_type: "144""
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What did BCYC's Form 144 disclose about planned sales?

The filing shows a planned sale of 2,937 restricted shares dated 04/02/2026. The entry is labeled as Equity Compensation and identifies the security as Common Stock.

Who recorded recent sales in the BCYC filing?

The filing shows recent dispositions by Alethia Young: 3,289 shares on 04/02/2026 and 4,334 shares on 01/05/2026. Each sale lists the share counts and dollar amounts.

How much cash was reported for recent Alethia Young sales in BCYC's filing?

The record shows $22,358.62 for 3,289 shares (04/02/2026) and $28,113.16 for 4,334 shares (01/05/2026). These amounts are included next to each sale line.

Does the filing state who receives proceeds from the planned sale?

The excerpt lists the planned sale as Issuer and labels it Equity Compensation, but it does not explicitly state the recipient of proceeds beyond that designation.
Bicycle Therapeutics Limited

NASDAQ:BCYC

View BCYC Stock Overview

BCYC Rankings

BCYC Latest News

BCYC Latest SEC Filings

BCYC Stock Data

352.02M
48.00M
Biotechnology
Pharmaceutical Preparations
Link
United Kingdom
CAMBRIDGE